Embecta Corp (STU:JX7)
€ 19.4 0 (0%) Market Cap: 1.14 Bil Enterprise Value: 2.41 Bil PE Ratio: 15.43 PB Ratio: 0 GF Score: 27/100

Embecta Corp at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2022 / 06:55PM GMT
Cecilia E. Furlong
Morgan Stanley, Research Division - Equity Analyst

Good afternoon, and thank you for joining us for the second day of the Morgan Stanley Healthcare Conference. I'm Cecilia Furlong. I'm medical device analyst here at Morgan Stanley. It's my pleasure to have Embecta new spin-out first conference with us, invite the CEO, Dev Kurdikar; CFO, Jake Elguicze. Thank you both very much for being here.

Devdatt Kurdikar
Embecta Corp. - President, CEO & Director

Thank you, Cecilia, for having us, and thank you for those in the room that are here to listen to our story. And just sort of before we get started, you recognize that we might be making forward-looking statements and obviously risks and uncertainties associated with that. And in our filings and the SEC website, including our latest 10-Q, always refer to that if you have any questions. But with that, ready to jump in. Jake and I are here and wanting to answer your questions, Cecilia.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot